MAS1 (C-term), 285-314 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-MAS1 (C-term), 285-314 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | MAS1 (C-term), 285-314 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.35 |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This MAS1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 285-314 amino acids from the C-terminal region of human MAS1. The structure of the MAS1 product indicates that itbelongs to the class of receptors that are coupled to GTP-bindingproteins and share a conserved structural motif, which is describedas a '7-transmembrane segment' following the prediction that thesehydrophobic segments form membrane-spanning alpha-helices. The MAS1protein may be a receptor that, when activated, modulates acritical component in a growth-regulating pathway to bring aboutoncogenic effects. |
| Immunogen | n/a |
| Other Names | [Proto-oncogene Mas; MAS1; MAS] |
| Gene, Accession # | [MAS1], Gene ID: 4142, NCBI: NP_002368.1, UniProt: P04201 |
| Catalog # | MBS9202317 |
| Price | $165, $370 |
| Order / More Info | MAS1 (C-term), 285-314 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Yang, J.K., et al. Diabetes Care 33(10):2271-2273(2010) Reis, A.B., et al. J. Mol. Histol. 41(1):75-80(2010) Trynka, G., et al. Gut 58(8):1078-1083(2009) Iwai, M., et al. Hypertens. Res. 32(7):533-536(2009) Vaz-Silva, J., et al. Reprod Sci 16(3):247-256(2009) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies